©2025 Stanford Medicine
Virtual Reality Behavioral Activation: An Intervention for Major Depressive Disorder
Not Recruiting
Trial ID: NCT04268316
Purpose
The primary purpose of this study is to test the safety and feasibility of virtual reality (VR) technology in the use of behavioral activation (BA) as a treatment for major depressive disorder (MDD). The secondary purpose of this study is to examine whether any evidence of clinical efficacy exists for VR delivered BA.
Official Title
Virtual Reality Behavioral Activation: An Intervention for Major Depressive Disorder
Stanford Investigator(s)
Kim Bullock, MD
Clinical Professor, Psychiatry and Behavioral Sciences
Eligibility
Inclusion Criteria:
* Patient must meet DSM V criteria for MDD
* Patient must be at least 18 years of age
* Patient must be English speaking
Exclusion Criteria:
* Substance Use Disorders in past year
* Any psychosis or bipolar I disorder
* Any seizure in the last 6 months or untreated epilepsy
* Current nonsuicidal self-injury or parasuicidal behavior
* Current suicidal urges and intent
Intervention(s):
device: Virtual Reality Behavioral Activation
behavioral: Behavioral Activation in real-life
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Margot Paul, M.S.
415-625-3127